Latest news
Comment
2024-10-23
Comment on Pharma Equity Group’s obtained patent protection in Japan for RNX-051
Comment
2024-04-05
Comment on Pharma Equity Group’s Positive Final Results From the Phase II Trial of the Drug Candidate RNX-051
Comment
2023-11-07
Comment on STENOCARE’s Updated Guidance and One-off Return of Products from Norway
Comment
2023-04-17
Analyst Group Comments on OrderYOYO’s Q1 Performance and Acquisition of Kingfood
Comment
2022-08-30